Get the Stockscreener App
4.38
2.67%
-0.12
Pulmatrix Inc stock is traded at $4.38, with a volume of 5,197.
It is down -2.67% in the last 24 hours and down -8.99% over the past month.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$4.50
Open:
$4.65
24h Volume:
5,197
Relative Volume:
0.49
Market Cap:
$16.00M
Revenue:
$11.68M
Net Income/Loss:
$-8.85M
P/E Ratio:
-1.8174
EPS:
-2.41
Net Cash Flow:
$-14.61M
1W Performance:
-10.25%
1M Performance:
-8.99%
6M Performance:
-32.62%
1Y Performance:
-19.34%
1-Day Range:
$4.38
$4.65
1-Week Range:
$4.38
$4.98
52-Week Range:
$4.33
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix Inc
Sector
Industry
Phone
(888) 355-4440
Address
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.38 | 16.44M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.03 | 110.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.75 | 76.23B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.76 | 61.08B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
914.59 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.56 | 43.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-18 | Initiated | H.C. Wainwright | Buy |
Pulmatrix Inc Stock (PULM) Latest News
Why Pulmatrix Inc. (2PU) stock is a strong analyst pickPortfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
How Pulmatrix Inc. stock trades during market volatilityTrade Analysis Report & Expert Approved Momentum Ideas - newser.com
Can Pulmatrix Inc. (2PU) stock double in coming years2025 Trading Volume Trends & Fast Moving Trade Plans - newser.com
Will Pulmatrix Inc. (2PU) stock see valuation expansion2025 Market Overview & Growth Focused Investment Plans - newser.com
Why institutional investors increase stakes in Pulmatrix Inc. (2PU) stockIPO Watch & Low Risk Investment Opportunities - newser.com
What consensus target says about Pulmatrix Inc. (2PU) stockStop Loss & Daily Stock Trend Reports - newser.com
Is Pulmatrix Inc. (2PU) stock prepared for digital transitionSell Signal & Real-Time Volume Trigger Notifications - newser.com
Is Pulmatrix Inc. (2PU) stock undervalued by metricsJuly 2025 Setups & Free Accurate Trade Setup Notifications - newser.com
What recovery options are there for Pulmatrix Inc.Treasury Yields & Fast Entry High Yield Stock Tips - newser.com
Is Pulmatrix Inc. stock a smart buy before Fed meetingJuly 2025 Gainers & Pattern Based Trade Signal System - newser.com
What RSI levels show for Pulmatrix Inc. (2PU) stockJuly 2025 Opening Moves & Expert Verified Stock Movement Alerts - newser.com
What market sentiment indicators show for Pulmatrix Inc. (2PU) stockMarket Rally & AI Driven Price Predictions - newser.com
Can Pulmatrix Inc. stock outperform in 2025 bull marketCEO Change & Precise Entry and Exit Recommendations - newser.com
Analyzing Pulmatrix Inc. with risk reward ratio chartsWeekly Profit Analysis & AI Optimized Trading Strategy Guides - newser.com
Will Pulmatrix Inc. stock go up soonTake Profit & Growth Oriented Trade Recommendations - newser.com
Trend analysis for Pulmatrix Inc. this weekWeekly Market Report & Risk Controlled Swing Alerts - newser.com
Using RSI to spot recovery in Pulmatrix Inc.Market Trend Summary & Fast Momentum Stock Entry Tips - newser.com
Will breakout in Pulmatrix Inc. lead to full recoveryBull Run & Verified Trade Idea Suggestions - newser.com
Is Pulmatrix Inc a good long term investmentHigh Beta Stocks & Your Roadmap to 10x Returns Starts Here - earlytimes.in
Is Pulmatrix Inc. stock gaining market shareJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com
Pulmatrix Inc Stock (PULM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):